Write your message
Volume 4, Issue 1 (Winter 2019)                   jogcr 2019, 4(1): 29-35 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Farzaneh F, Jamdar F, Younesi S, Taheri Amin M, Saadati P, Navidpour F, et al . The Trend of Abnormal Cervical Cytology Among Iranian Women During Recent Years from 2013 to 2016 . jogcr. 2019; 4 (1) :29-35
URL: http://jogcr.com/article-1-226-en.html
1- Fellowship in Gynecologic-oncology (UK), Mcphil (UK), Head of the Preventive Gynaecology Research Center (PGRC) Shahid Beheshti University of Medical Sciences, Imam Hossein Hospital, Tehran, Iran , farahzaneh@yahoo.com
2- Gynecology oncology fellowship, Preventive Gynecologic-oncology Research Center (PGRC) Shahid Beheshti University of Medical Sciences, Imam Hossein Hospital, Tehran, Iran, Gynecology oncology fellowship, Preventive Gynecologic-oncology Research Center (PGRC) Shahid Beheshti University of Medical Sciences, Imam Hossein Hospital, Tehran, Iran
3- Technical Manager of Nilou Medical Laboratory, Tehran, Iran, Technical Manager of Nilou Medical Laboratory, Tehran, Iran
4- Doctor of Clinical Laboratory Science, CEO of Nilou Medical Laboratory, Tehran, Iran, CEO of Nilou Medical Laboratory, Tehran, Iran
5- Anatomical and Clinical Pathologist, founder of Nilou Medical Laboratory, Tehran, Iran, Anatomical and Clinical Pathologist, founder of Nilou Medical Laboratory, Tehran, Iran
6- MSc in Midwifery, Manager of Post Analytical-Quality Control Department in Nilou Medical Laboratory, Tehran, Iran, MSc in Midwifery, Manager of Post Analytical-Quality Control Department in Nilou Medical Laboratory, Tehran, Iran
7- Anatomical and Clinical Pathologist, Manager of Pathology Department in Nilou Medical Laboratory, Tehran, Iran, Anatomical and Clinical Pathologist, Manager of Pathology Department in Nilou Medical Laboratory, Tehran, Iran
8- Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran, Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
9- Preventive Gynaecology Research Center (PGRC) Shahid Beheshti University of Medical Science, Imam Hossein Hospital, Tehran, Iran, Preventive Gynaecology Research Center (PGRC) Shahid Beheshti University of Medical Science, Imam Hossein Hospital, Tehran, Iran
Abstract:   (282 Views)

Background: Cervical cancer is one of the common cancers in developing countries, which has a high rate of mortality. This study aimed to evaluate the prevalence of abnormal cervical cytology among Iranian women.
Methods: In this cross-sectional study, cervical cytological results of 137,484 Iranian women, who were screened for cervical cancer in Tehran and 12 other provinces of Iran from 2013 to 2016, were investigated. The Pap smear was prepared by a liquid-based method and evaluated by a pathologist.
Results: The overall prevalence of abnormal cervical cytology in the studied population was 3%. The mean age of the population was 35.77 ± 9.6. In this study, the prevalence of abnormal cytology in 2013, 2014, 2015, and 2016 was 2.10%, 2.68%, 3.47%, and 3.60%, respectively. The rate of the abnormal Pap smear has increased over the years, and this trend has been statistically significant (P<0.001). In this population, atypical squamous cells of undetermined significance (ASCUS) cytology was the most common abnormal Pap smear (1.96%).
Conclusion: In this study, the prevalence of abnormal cervical cytology has been significantly increased in Iran in recent years. This increase requires careful monitoring of general education programs, strict cervical cancer screening, and routine vaccination against HPV infection.

Full-Text [PDF 320 kb]   (43 Downloads) |   |   Full-Text (HTML)  (72 Views)  

In this study, the prevalence of abnormal cervical cytology has been significantly increased in Iran in recent years. This increase requires careful monitoring of general education programs, strict cervical cancer screening, and routine vaccination against HPV infection.


Systematic Review: Original Research | Subject: Gynecology Oncology
Received: 2018/09/9 | Accepted: 2019/01/25 | Published: 2019/10/1
* Corresponding Author Address: Fellowship in Gynecologic-oncology (UK), Mcphil (UK), Head of the Preventive Gynaecology Research Center (PGRC) Shahid Beheshti University of Medical Sciences, Imam Hossein Hospital, Tehran, Iran

References
1. Siegel R, Ward E, Brawley O, Jemal A. The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. Ca-a Cancer Journal for Clinicians. 2011;61(4):212-36. [DOI:10.3322/caac.20121] [PMID]
2. Quinn M, Babb P, Jones J, Allen E. Papers. Bmj. 1999;318(7188):904. [DOI:10.1136/bmj.318.7188.904] [PMID] [PMCID]
3. Willoughby BJ, Faulkner K, Stamp E, Whitaker C. A descriptive study of the decline in cervical screening coverage rates in the North East and Yorkshire and the Humber regions of the UK from 1995 to 2005. Journal of Public Health. 2006;28(4):355-60. [DOI:10.1093/pubmed/fdl062] [PMID]
4. Ferlay J. GLOBOCAN 2000. Cancer incidence, mortality and prevalence worldwide, version 1.0. IARC cancerbase. 2001.
5. Jemal A, Center MM, DeSantis C, Ward EM. Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology and Prevention Biomarkers. 2010;19(8):1893-907. [DOI:10.1158/1055-9965.EPI-10-0437] [PMID]
6. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA: a cancer journal for clinicians. 2015;65(2):87-108. [DOI:10.3322/caac.21262] [PMID]
7. Papanicolaou GN, Traut HF. The diagnostic value of vaginal smears in carcinoma of the uterus. American Journal of Obstetrics & Gynecology. 1941;42(2):193-206. [DOI:10.1016/S0002-9378(16)40621-6]
8. Chaichian S, Khateri S, Moradi Y, Khosravi Shadmani F, Mansori K, Khazaei Z, et al. Trends in cervical cancer incidence in Iran from 2003 to 2009. Middle East Journal of Cancer. 2018;9(1):57-63.
9. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. The Journal of pathology. 1999;189(1):12-9. https://doi.org/10.1002/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F [DOI:10.1002/(SICI)1096-9896(199909)189:13.0.CO;2-F]
10. Kaufman RH, Adam E, Icenogle J, Lawson H, Lee N, Reeves KO, et al. Relevance of human papillomavirus screening in management of cervical intraepithelial neoplasia. American journal of obstetrics and gynecology. 1997;176(1):87-92. [DOI:10.1016/S0002-9378(97)80017-8]
11. Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. JNCI: Journal of the National Cancer Institute. 1993;85(12):958-64. [DOI:10.1093/jnci/85.12.958] [PMID]
12. Khan MJ, Partridge EE, Wang SS, Schiffman M, Group ASCoUSLGSILTS. Socioeconomic status and the risk of cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA‐positive women with equivocal or mildly abnormal cytology. Cancer. 2005;104(1):61-70. [DOI:10.1002/cncr.21129] [PMID]
13. Jamdar F, Farzaneh F, Navidpour F, Younesi S, Balvayeh P, Hosseini M, et al. Prevalence of human papillomavirus infection among Iranian women using COBAS HPV DNA testing. Infectious agents and cancer. 2018;13(1):6. [DOI:10.1186/s13027-018-0178-5] [PMID] [PMCID]
14. Afrakhteh M, Khodakarami N, Moradi A, Alavi E, Shirazi FH. A study of 13315 papanicolau smear diagnoses in Shohada Hospital. Journal of family and reproductive health. 2007;1(2):74-8.
15. American cancer society , www.cancer.org Last Revised: January 23, 2019
16. Nour NM. Cervical cancer: a preventable death. Reviews in Obstetrics and Gynecology. 2009;2(4):240.
17. Bal MS, Goyal R, Suri AK, Mohi MK. Detection of abnormal cervical cytology in Papanicolaou smears. Journal of Cytology/Indian Academy of Cytologists. 2012;29(1):45. [DOI:10.4103/0970-9371.93222] [PMID] [PMCID]
18. Sadan O, Schejter E, Ginath S, Bachar R, Boaz M, Menczer J, et al. Premalignant lesions of the uterine cervix in a large cohort of Israeli Jewish women. Archives of gynecology and obstetrics. 2004;269(3):188-91. [DOI:10.1007/s00404-002-0371-y] [PMID]
19. Thistle P, Chirenje Z. Cervical cancer screening in a rural population of Zimbabwe. The Central African journal of medicine. 1997;43(9):246-51.
20. Nokiani FA, Akbari H, Rezaei M, Madani H, Ale Agha M. Cost--effectiveness of pap smear in Kermanshah, Iran. Asian Pac J Cancer Prev. 2008;9(1):107-10.
21. Massomi Z, Khani S, Gharosian M, Farhadian M, Shayan A. The Prevalence of Abnormal Pap Smears in females Referred to Health Centers Affiliated to Medical Sciences During the Years 2012 to 2016. J Educ Community Health. 2016;3(2):16-22. [DOI:10.21859/jech-03023]
22. Maraqa B, Lataifeh I, Otay L, Badran O, Nouri YQ, Issam I, et al. Prevalence of Abnormal Pap Smears: A Descriptive Study from a Cancer Center in a Low-Prevalence Community. Asian Pacific journal of cancer prevention: APJCP. 2017;18(11):3117.
23. Kapila K, George SS, Al-Shaheen A, Al-Ottibi M, Pathan SK, Sheikh ZA, et al. Changing spectrum of squamous cell abnormalities observed on Papanicolaou smears in Mubarak Al-Kabeer Hospital, Kuwait, over a 13-year period. Medical Principles and Practice. 2006;15(4):253-9. [DOI:10.1159/000092986] [PMID]
24. Al MZ, Al SM, Al TS, Al SA, Coetsee K, Balayah Z, et al. Age Specific Cytological Abnormalities in Women Screened for Cervical Cancer in the Emirate of Abu Dhabi. Asian Pacific journal of cancer prevention: APJCP. 2015;16(15):6375-9. [DOI:10.7314/APJCP.2015.16.15.6375] [PMID]
25. Altaf FJ. Cervical cancer screening with pattern of pap smear. Saudi Med J. 2006;27(10):1498-502.
26. Elhakeem HA, Al-Ghamdi AS, Al-Maghrabi JA. Cytopathological pattern of cervical Pap smear according to the Bethesda system in Southwestern Saudi Arabia. Saudi medical journal. 2005;26(4):58892.
27. Atilgan R, Celik A, Boztosun A, Ilter E, Yalta T, Ozercan R. Evaluation of cervical cytological abnormalities in Turkish population. Indian Journal of Pathology and Microbiology. 2012;55(1):52. [DOI:10.4103/0377-4929.94856] [PMID]
28. Rossi PG, Ricciardi A, Cohet C, Palazzo F, Furnari G, Valle S, et al. Epidemiology and costs of cervical cancer screening and cervical dysplasia in Italy. BMC Public Health. 2009;9(1):71. [DOI:10.1186/1471-2458-9-71] [PMID] [PMCID]
29. Arbyn M, Van Nieuwenhuyse A, Bogers J, De Jonge E, De Beeck LO, Matheï C, et al. Cytological screening for cervical cancer in the province of Limburg, Belgium. European Journal of Cancer Prevention. 2011;20(1):18-24. [DOI:10.1097/CEJ.0b013e32833ecbc6] [PMID]
30. Shipitsyna E, Zolotoverkhaya E, Kuevda D, Nasonova V, Romanyuk T, Khachaturyan A, et al. Prevalence of high-risk human papillomavirus types and cervical squamous intraepithelial lesions in women over 30 years of age in St. Petersburg, Russia. Cancer epidemiology. 2011;35(2):160-4. [DOI:10.1016/j.canep.2010.08.010] [PMID]
31. El All HSA, Refaat A, Dandash K. Prevalence of cervical neoplastic lesions and human papilloma virus infection in Egypt: national cervical cancer screening project. Infectious agents and cancer. 2007;2(1):12. [DOI:10.1186/1750-9378-2-12] [PMID] [PMCID]
32. Stolnicu S, Musca S, Micu D, Micu L, Moldovan C, Puscasiu L. Prevalence of abnormal Pap smears in a consecutive and previously unscreened population in Romania. International Journal of Gynecology & Obstetrics. 2014;124(2):156-9. [DOI:10.1016/j.ijgo.2013.07.030] [PMID]
33. Jena A, Bharathi T, Reddy S, Manilal B, Patnayak R, Phaneendra B. Papanicolaou (Pap) test screening of staff members of a tertiary care teaching hospital in South India. J Clin Sci Res. 2012;1:174-7.
34. Gupta S, Iyengar S, Jain B. Trend of Cervical Dysplsia And Cervical Cancer -in Papanicolaou Smears in Perimenopausal Females In Tertiary Care Centre, Gwalior Madhya Pradesh. Journal of Dental and Medical Sciences 2017;16(12):10-3. [DOI:10.9790/0853-1601111013]
35. Khodakarami N, Clifford GM, Yavari P, Farzaneh F, Salehpour S, Broutet N, et al. Human papillomavirus infection in women with and without cervical cancer in Tehran, Iran. International journal of cancer. 2012;131(2):E156-E61. [DOI:10.1002/ijc.26488] [PMID]
36. Momenimovahed Z, Salehiniya H. Cervical cancer in Iran: integrative insights of epidemiological analysis. BioMedicine. 2018;8(3). [DOI:10.1051/bmdcn/2018080318] [PMID] [PMCID]
37. Koh W-J, Greer BE, Abu-Rustum NR, Apte SM, Campos SM, Cho KR, et al. Cervical cancer, version 2.2015. Journal of the National Comprehensive Cancer Network. 2015;13(4):395-404. [DOI:10.6004/jnccn.2015.0055] [PMID]
38. Smith RA, Andrews KS, Brooks D, Fedewa SA, Manassaram-Baptiste D, Saslow D, et al. Cancer screening in the United States, 2018: a review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Cancer Journal for Clinicians. 2018;68(4):297-316. [DOI:10.3322/caac.21446] [PMID]
39. Khalkhali HR, Gharaaghaji R, Valizadeh R, Kousehlou Z, Ayatollahi H. Ten Years' Survival in Patients with Cervical Cancer and Related Factors in West Azerbaijan Province: Using of Cox Proportion Hazard Model. Asian Pacific Journal of Cancer Prevention. 2019;20(5):1345-51. [DOI:10.31557/APJCP.2019.20.5.1345] [PMID]
40. Moscicki A-B, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, et al. Regression of low-grade squamous intra-epithelial lesions in young women. The Lancet. 2004;364(9446):1678-83. [DOI:10.1016/S0140-6736(04)17354-6]
41. Edelman M, Fox AS, Alderman EM, Neal W, Shapiro A, Silver EJ, et al. Cervical Papanicolaou smear abnormalities in inner city Bronx adolescents: prevalence, progression, and immune modifiers. Cancer Cytopathology: Interdisciplinary International Journal of the American Cancer Society. 1999;87(4):184-9. https://doi.org/10.1002/(SICI)1097-0142(19990825)87:4<184::AID-CNCR4>3.0.CO;2-# [DOI:10.1002/(SICI)1097-0142(19990825)87:43.0.CO;2-#]
42. Mount SL, Papillo JL. A study of 10 296 pediatric and adolescent Papanicolaou smear diagnoses in Northern New England. Pediatrics. 1999;103(3):539-45. [DOI:10.1542/peds.103.3.539] [PMID]
43. Eissenberg T, Shihadeh A. Waterpipe tobacco and cigarette smoking: direct comparison of toxicant exposure. American journal of preventive medicine. 2009 D;37(6):518-23 [DOI:10.1016/j.amepre.2009.07.014] [PMID] [PMCID]
44. Schabath MB, Villa LL, Lazcano-Ponce E. Smoking and human papillomavirus (HPV) infection in the HPV in Men (HIM) study. Cancer Epidemiol Biomarkers Prev. 2012;21(1):102-10 [DOI:10.1158/1055-9965.EPI-11-0591] [PMID] [PMCID]
45. Ghaemdoust, F., Nahvijou, A., Zendehdel, K. and Farzaneh, F. 2019. Waterpipe as a Risk Factor for Genital Warts? A Case Report. Basic & Clinical Cancer Research. 2019;11(3)
46. Staples JN, Wong MS, Rimel B. An educational intervention to improve human papilloma virus (HPV) and cervical cancer knowledge among African American college students. Gynecologic oncology. 2018;149(1):101-5. [DOI:10.1016/j.ygyno.2017.10.015] [PMID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2019 All Rights Reserved | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.